UBE2V1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.423800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.700200E-01
Normal-vs-Stage2
3.999800E-02
Normal-vs-Stage3
5.309000E-01
Normal-vs-Stage4
2.393000E-01
Stage1-vs-Stage2
1.877040E-01
Stage1-vs-Stage3
7.385200E-01
Stage1-vs-Stage4
1.109170E-01
Stage2-vs-Stage3
1.356580E-01
Stage2-vs-Stage4
6.015600E-01
Stage3-vs-Stage4
2.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.582100E-02
Normal-vs-AfricanAmerican
2.305600E-01
Normal-vs-Asian
3.902200E-01
Caucasian-vs-AfricanAmerican
4.657800E-01
Caucasian-vs-Asian
6.436000E-01
AfricanAmerican-vs-Asian
6.839400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.365900E-02
Normal-vs-Female
1.776240E-01
Male-vs-Female
4.534800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.756600E-01
Normal-vs-Age(41-60Yrs)
2.475200E-01
Normal-vs-Age(61-80Yrs)
4.470200E-01
Normal-vs-Age(81-100Yrs)
6.436000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.029200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.075800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.863200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.301200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.358970E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.188400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.576400E-01
Normal-vs-Daily Drinker
1.999560E-01
Normal-vs-Weekly Drinker
2.258000E-01
Normal-vs-Occasional Drinker
1.538830E-01
Normal-vs-Social Drinker
6.663600E-01
Non Drinker-vs-Daily Drinker
1.035010E-01
Non Drinker-vs-Weekly Drinker
1.040220E-01
Non Drinker-vs-Occasional Drinker
2.615600E-03
Non Drinker-vs-Social Drinker
2.567800E-01
Daily Drinker-vs-Weekly Drinker
8.979200E-01
Daily Drinker-vs-Occasional Drinker
2.903600E-01
Daily Drinker-vs-Social Drinker
5.480000E-01
Weekly Drinker-vs-Occasional Drinker
3.910400E-01
Weekly Drinker-vs-Social Drinker
5.081000E-01
Occasional Drinker-vs-Social Drinker
4.435700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.437600E-01
Normal-vs-Grade 2
9.104600E-01
Normal-vs-Grade 3
9.316200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.313900E-02
Grade 1-vs-Grade 3
3.960100E-02
Grade 1-vs-Grade 4
8.437600E-01
Grade 2-vs-Grade 3
4.535200E-01
Grade 2-vs-Grade 4
9.104600E-01
Grade 3-vs-Grade 4
9.316200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.142000E-01
Normal-vs-NonDiabetic
3.056000E-02
Diabetic-vs-NonDiabetic
1.488200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.368200E-01
Normal-vs-NoPancreatitis
1.162390E-01
Pancreatitis-vs-NoPancreatitis
8.660400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.228800E-01
Normal-vs-N1
4.668000E-02
N0-vs-N1
4.416000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.569900E-04
Normal-vs-TP53-NonMutant
4.726000E-01
TP53-Mutant-vs-TP53-NonMutant
2.26449999999323E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
